Today, ECLLA is bringing together clinicians, patient advocates, care partners, nurse, and policy expert from across Europe for our multi-stakeholder panel discussion: “Time Off Treatment in CLL: Clinical Control and Patient Priorities in Fixed-Duration Treatment”

Held alongside EHA 2026, the discussion explores the clinical, emotional, and practical realities of treatment-free periods in CLL, as well as the importance of communication, shared decision-making, monitoring, and holistic patient support.

A huge thank you to our distinguished panellists and everyone joining us in person and online for contributing to this important European conversation.

Together, we are helping to strengthen dialogue around the evolving landscape of CLL care and ensuring that patient perspectives remain at the heart of discussions about treatment and quality of life.